Analyst Research: DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

1.27USD
2 Aug 2013
Price Change (% chg)

$0.02 (+1.60%)
Prev Close
$1.25
Open
$1.25
Day's High
$1.27
Day's Low
$1.23
Volume
10,150
Avg. Vol
121,323
52-wk High
$1.85
52-wk Low
$0.61

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - DURECT CORPORATION (DRRX-O) 1 Aug 2013 Thomson Reuters Stock Report 12 25.00
DURECT Corp 27 Jul 2013 S&P Capital IQ Quantitative Report 5 58.00
DURECT CP (DRRX) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
DURECT Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
TheStreet.com Ratings Stock Report For: DURECT CORP (DRRX) 20 Jul 2013 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Felix Theeuwes

75 1998 Chairman of the Board, Chief Scientific Officer

James Brown

56 1998 President, Chief Executive Officer, Director

Matthew Hogan

53 2006 Chief Financial Officer

Su Il Yum

73 2007 Executive Vice President - Pharmaceutical Systems Research and Development

David Hoffmann

68 2010 Lead Independent Director
Search Stocks